SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 43.02 |
| Enterprise Value ($M) | -15.42 |
| Book Value ($M) | 161.36 |
| Book Value / Share | 1.88 |
| Price / Book | 0.27 |
| NCAV ($M) | 2.20 |
| NCAV / Share | 0.03 |
| Price / NCAV | 19.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.59 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.50 |
| Current Ratio | 1.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 194.05 |
| Assets | 353.22 |
| Liabilities | 191.85 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 6.59 |
| Operating Income | -135.17 |
| Net Income | -126.57 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -110.14 |
| Cash from Investing | 47.48 |
| Cash from Financing | 74.56 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 4.70 | -26.57 | |
| 13G | Casdin Capital, LLC | 5.40 | 42.96 | |
| 13G/A | Fmr Llc | 2.98 | -30.20 | |
| 13G/A | Boxer Capital Management, LLC | 3.70 | ||
| 13G | Bain Capital Life Sciences Opportunities III, LP | 6.60 | ||
| 13G | Boxer Capital, LLC | 5.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 119,131 | 645,119 | 18.47 | |
| 68,340 | 497,021 | 13.75 | |
| 77,669 | 329,033 | 23.61 | |
| 122,028 | 509,339 | 23.96 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INZY – Inozyme Pharma, Inc. | IOBT – IO Biotech, Inc. |
| IONS – Ionis Pharmaceuticals, Inc. | IRWD – Ironwood Pharmaceuticals, Inc. |
| JAZZ – Jazz Pharmaceuticals plc |
Financial data and stock pages provided by
Fintel.io